Bayer Crop Science

BioDirect dsRNA — spray-on RNAi crop-protection program.

Country
Germany
Ticker
BAYN.DE
Pipeline
Coverage
CNEUINUS
agri-inputs-biocontrol
crop-biotech
Regulatorsusda-aphisepaefsamoa-china

Verifiable facts

FactValueSource
FundingBayer submitted BioDirect to the U.S. EPA in 2019, and in 2021, Bayer licensed the underlying patent to GreenLight Biosciences for production.mdpi.com
Regulatory approvalBioDirect is in development; it is not yet approved as a commercial spray-on RNAi product. The world's first sprayable dsRNA biopesticide, Ledprona, was approved by the U.S. EPA in 2023, but is a product of GreenLight Biosciences.mdpi.com
Production siteBayer's Crop Science production facilities in Germany are being streamlined, with Monheim am Rhein serving as the primary center for crop protection research and development. Dormagen remains a key production site.bayer.com
HeadcountBayer Group employed approximately 93,000 people in 2024.bayer.com
RevenueBayer Crop Science division reported sales of €21,622 million in 2025.reports.bayer.com

Independent sources: mdpi.com · reports.bayer.com

Technologies
NameClusterRisk
Genetic engineering & bio-selectioncrop-biotechNo data
Precision Plant Breeding & CRISPR Crop Editingcrop-biotechLow
RNAi biopesticidesagri-inputs-biocontrolMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.